FY-2021 Top 20 Commercially Successful Inventions
|
|
VACCINES & THERAPEUTICS |
| Rank |
|
|
|
| 1 |
Anti-Coronavirus Antibodies |
Mascola, et al. |
NIAID |
| 2 |
Nutritional Supplement to Treat Macular Degeneration |
Ferris, et al. |
NEI |
| 3 |
Proteosome Inhibitor for Treatment of Multiple Myeloma |
Gupta, et al. |
NCI |
| 6 |
Pox Virus Based Veterinary Vaccines |
Moss, et al. |
NIAID |
| 9 |
Multivalent Human-Bovine Rotavirus Vaccine |
Kapikian, et al. |
NIAID |
| 12 |
Palifermin for Treatment of Oral Mucositis |
Rubin, et al. |
NCI |
| 15 |
CAR T-cell Therapy for Multiple Myeloma |
Kochenderfer, et al. |
NCI |
| 16 |
AAV Gene Therapy for Vision Loss |
Kaludov, et al. |
NIDCR |
| |
|
|
|
DIAGNOSTICS |
| Rank |
|
|
|
| 4 |
DNA Probe for Breast Cancer Diagnosis (HER-2) |
King, et al. |
NCI |
| 5 |
HIV-1 Diagnostic Test Kits |
Gallo, et al. |
NCI |
| 13 |
HIV-1 Genotyping Assays |
Medabalimi, et al. |
NCI |
| |
|
|
|
|
|
INSTRUMENTATION & DEVICES |
| Rank |
|
|
|
| 10 |
Transcranial Magnetic Stimulation System |
Zangen, et al. |
NIDA |
| |
|
|
|
|
|
RESEARCH MATERIALS & SERVICES |
| Rank |
|
|
|
| 7 |
Cell Lines Established from Certain Human Tumors |
Oie, et al. |
NCI |
| 8 |
Murine Colon 38 Cell Line |
Hollingshead, et al. |
NCI |
| 11 |
C8166-45 Cell Line |
Franchini, et al. |
NCI |
| 14 |
Human Multi-Drug Resistance Clone |
Gottesman, et al. |
NCI |
| 17 |
Human Mast Cell Line LAD2 |
Kirshenbaum, et al. |
NIAID |
| 18 |
Pan02 Cell Line |
Hollingshead, et al. |
NCI |
| 19 |
Anti-DNA-RNA Hybrid Clone S9.6 |
Leppla, et al. |
NIAID |
| 20 |
GMP-Qualified 293 Cell Line |
Schwartz, et al. |
NCI |
